Civil Proceedings
- Local infliximab treatment in ileocolonic anastomotic Crohn’s disease recurrence: Efficacy at 12 months follow-up1/24/2022 0:00
- The benefit of a tailored patient preference intervention in adherence to 5-ASA medication in ulcerative colitis: Results from a randomised controlled trial1/24/2022 0:00
- Endoscopic outcome of medium term adalimumab therapy in patients with Crohn’s disease. National data from Hungary1/24/2022 0:00
- Mucosal healing with methotrexate in Crohn’s disease: A prospective comparative study with azathioprine and infliximab1/24/2022 0:00
- UK inflammatory bowel disease audit: IBD nurse correlations between 2006 and 20081/24/2022 0:00
- A multidisciplinary virtual biologic clinic: Is it worthwhile?1/24/2022 0:00
- Adalimumab versus Infliximab clinical comparision: Longitudinal study1/24/2022 0:00
- Efficacy and safety of chronic hepatitis C treatment with pegylated interferon alpha 2a/b and ribavirin in patients with inflammatory bowel disease1/24/2022 0:00
- Early post-operative endoscopic recurrence in Crohn’s disease in an Italian multicentric cohort1/24/2022 0:00
- Long term efficacy of granulocyte-monocyte-apheresis in ulcerative colitis. The Italian Registry of Therapeutic Apheresis1/24/2022 0:00
- Evaluation of potential correlations between serum adalimumab concentration and remission in patients with Crohn’s disease in CLASSIC I and II1/24/2022 0:00
- Fecal calprotectin may differentiate between IBS and IBD symptomes in IBD patients1/24/2022 0:00
- Paradoxical effect of IL13 blockage in inflamed colon mucosa of ulcerative colitis patients1/24/2022 0:00
- Emerging safety profile of vedolizumab: A novel, selective integrin inhibitor for treatment of IBD1/24/2022 0:00
- Certolizumab pegol demonstrates efficacy in maintaining response and remission in patients with active Crohn’s disease regardless of their immunosuppressant treatment status at entry to the PRECiSE 2 study1/24/2022 0:00
- Immunomodulatory treatment reduces the need for ileocecal resection in Crohn’s disease1/24/2022 0:00
- Predictors of suboptimal medication adherence in IBD patients: A single Australian tertiary centre experience1/24/2022 0:00
- Efficacy of once-daily versus twice-daily mesalazine (PENTASA®): Sub-analysis of the left-sided colitis population in the randomised PODIUM trial1/24/2022 0:00
- Use of immunosuppressants and anti-TNF for inflammatory bowel diseases (IBD) in current practice: Data from a French regional survey1/24/2022 0:00
- Adalimumab therapy in ulcerative colitis patients with previous colectomy1/24/2022 0:00
- Does cognitive behavioural therapy (CBT) improve outcomes in IBD? Feasibility, patient acceptance and preliminary results1/24/2022 0:00
- Osteoporosis prophylaxis in IBD: Still a neglected field?1/24/2022 0:00
- What’s cheapest, intravenous iron sucrose- or intravenous iron carboxymaltose treatment in IBD-patients? It depends on the economic evaluation perspective!1/24/2022 0:00
- Clinical benefit of dietary advice in ulcerative colitis (UC): Results of a pilot study1/24/2022 0:00
- Comparative efficiency of current strategies in the treatment for ulcerative colitis severe relapses1/24/2022 0:00
- Are there gender-related differences in the therapeutic management of patients suffering from inflammatory bowel disease? A subgroup analysis of a prospective multicentre online-based trial1/24/2022 0:00
- Bone mineral density assessment in patients with inflammatory bowel diseases1/24/2022 0:00
- What influences persistence with mesalazine therapy? Results from a large pharmacy database1/24/2022 0:00
- Continuing persistence: United States prescription database results from patients persistent with long-term mesalazine therapy1/24/2022 0:00
- The effect of perianal disease on perceived severity of Crohn’s disease1/24/2022 0:00
- Usefulness of oral beclometasone dipropionate to induce remission in active ulcerative colitis patients: Results from the RECLICU study1/24/2022 0:00
- Ask the doctor about inflammatory bowel disease on the Internet: Experiences after more than one thousand questions1/24/2022 0:00
- Response time of azathioprine in steroid-dependent patients with ulcerative colitis: How much time do we to wait?1/24/2022 0:00
- Smoking in Crohn’s disease: Can we do more?1/24/2022 0:00
- Long-term scheduled therapy with Infliximab in inflammatory bowel disease: Results from a single-centre cohort1/24/2022 0:00
- Time trends in the use of medication and intestinal surgery in a Dutch cohort of patients with Crohn’s disease (1980 2004)1/24/2022 0:00
- Immune response to hepatitis B vaccination in patients with inflammatory bowel disease1/24/2022 0:00
- Appropriateness of treatment for fistulizing Crohn’s disease: Findings from a nationwide inflammatory bowel disease cohort1/24/2022 0:00
- Adalimumab for ulcerative colitis patients previously treated with Infliximab: Short and long-term outcomes1/24/2022 0:00
- Safety of thiopurine therapy in inflammatory bowel disease (IBD): Long-term follow-up study of 3,900 patients1/24/2022 0:00
- Cost effectiveness of ulcerative colitis treatment in Germany: A comparison of Mezavant® and Asacol®1/24/2022 0:00
- Maintenance of mucosal healing in ulcerative colitis patients with once-daily versus twice-daily dosing of mesalazine: An analysis of mucosal healing in the PODIUM trial1/24/2022 0:00
- Efficacy of oral iron treatment in iron deficiency anemia in inflammatory bowel disease patients1/24/2022 0:00
- Preliminary outcomes from an MMX® mesalazine patient experience program in patients with ulcerative colitis1/24/2022 0:00
- Results of a controlled trial on multimodal guideline implementation in inflammatory bowel diseases1/24/2022 0:00
- The safety and efficacy of ciclosporin in the outpatient setting1/24/2022 0:00
- Enterocutaneous fistulas in Crohn’s disease clinical characteristics and response to treatment1/24/2022 0:00
- Azathioprine withdrawal in Crohn’s disease: Never-ending story?1/24/2022 0:00
- Do IBD patients change their treating specialist physicians? If so, does it matter?1/24/2022 0:00
- What is the frequency of 5-ASA administration in colitis within clinical practice?1/24/2022 0:00